1. Home
  2. SNX vs RDY Comparison

SNX vs RDY Comparison

Compare SNX & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TD SYNNEX Corporation

SNX

TD SYNNEX Corporation

HOLD

Current Price

$161.40

Market Cap

13.9B

Sector

Technology

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.41

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNX
RDY
Founded
1980
1984
Country
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9B
11.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SNX
RDY
Price
$161.40
$14.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
1
Target Price
$168.60
$16.90
AVG Volume (30 Days)
767.9K
2.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.20%
0.50%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.14
$6.12
Revenue Next Year
$4.05
$2.58
P/E Ratio
$16.07
$18.68
Revenue Growth
N/A
N/A
52 Week Low
$92.23
$12.26
52 Week High
$175.56
$16.17

Technical Indicators

Market Signals
Indicator
SNX
RDY
Relative Strength Index (RSI) 51.91 63.60
Support Level $155.66 $14.06
Resistance Level $175.56 $14.23
Average True Range (ATR) 5.26 0.24
MACD -0.66 0.08
Stochastic Oscillator 28.86 95.41

Price Performance

Historical Comparison
SNX
RDY

About SNX TD SYNNEX Corporation

TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: